| 1992 |
B-TFIID, purified from mammalian cell extracts, consists of two subunits: TBP and a 170 kDa TAF (BTAF1/TAFII170); the highly purified B-TFIID fractions possess (d)ATPase activity. |
Biochemical purification, subunit composition analysis, ATPase activity assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
1387711
|
| 1994 |
Yeast TAFII170 (Taf170) is encoded by MOT1 and forms a distinct TBP-Taf170 binary complex separate from the multisubunit TFIID complex, establishing it as a bona fide TAF with a unique role in transcriptional regulation. |
Protein sequencing of purified TAF, co-fractionation, complex resolution by biochemical methods |
The Journal of biological chemistry |
High |
8083216
|
| 1997 |
Recombinant human TAFII170 (BTAF1) has (d)ATPase activity, and co-fractionation/co-precipitation experiments confirmed it is the TAF subunit of B-TFIID. Its primary structure shows homology to yeast MOT1 and Drosophila moira, consistent with a role as a global regulator of pol II transcription. |
cDNA cloning, recombinant protein expression, ATPase assay, co-fractionation, co-precipitation |
Proceedings of the National Academy of Sciences of the United States of America |
High |
9342322
|
| 2001 |
BTAF1 (TAFII170) interacts with TBP via three amino-terminal regions (residues 2–137, 290–381, and 380–460), each containing HEAT repeats; the interaction targets the concave DNA-binding surface of TBP, and region 290–381 inhibits TBP–TATA box complex formation, supporting a mechanism by which BTAF1 induces high-mobility TBP–DNA binding through reversible competition for TBP's concave surface. |
Deletion mutagenesis, binding assays with altered-specificity TBP mutant (TBPAS), competitive inhibition assays with TAFII230, TBP-DNA binding assays |
Molecular and cellular biology |
High |
11585931
|
| 2003 |
BTAF1 (and its yeast ortholog Mot1p) can dissociate TBP from TATA DNA complexes in an ATP hydrolysis-dependent manner, functioning both as a repressor and positive regulator of pol II transcription by dynamically redistributing TBP on promoters. |
Review synthesizing genetic and biochemical experiments (ATP-dependent TBP dissociation assays, genetic repressor/activator analyses) |
Gene |
Medium |
14557059
|
| 2004 |
NC2alpha (DRAP1) physically interacts with BTAF1 and stimulates BTAF1's ATP-dependent association with TBP; NC2beta does not associate with BTAF1 and interferes with the BTAF1–TBP interaction. The stimulatory effect of NC2alpha does not require BTAF1's ATPase activity or phosphorylation of NC2alpha. |
Co-immunoprecipitation, cell extract binding assays with ATP, ATPase-deficient BTAF1 mutants, domain-specific interaction experiments |
Molecular and cellular biology |
Medium |
15509807
|
| 2004 |
Electron microscopy single-particle analysis of native and recombinant B-TFIID determined its molecular architecture at 28 Å resolution: a 15×9 nm structure with a large ~170 kDa domain subdivided into two subdomains and a protruding thumb. Immunolabeling localized the C-terminus of BTAF1 in the 170-kDa domain, the N-terminus and TBP at the end of the thumb, and the central portion of BTAF1 at the base of the thumb. |
Electron microscopy, single-particle image analysis, immunolabeling with antibodies against BTAF1 termini and TBP |
The Journal of biological chemistry |
High |
14988402
|
| 2000 |
The human BTAF1 (TAFII170) gene contains 37 introns, lacks a canonical TATA box and initiator element at its promoter, maps to chromosome 10q22-q23, and a 264 bp promoter fragment is sufficient to direct transcription as shown by deletion analysis. |
Genomic cloning, ribonuclease-protection assays, promoter deletion analysis, chromosomal mapping by two independent methods |
The Biochemical journal |
Medium |
10642510
|